Email Address
(this will be your username)
Full Name
Password Confirm Password Contact Number Country
Barcelona 2017 Congress Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Hotel Information

Thursday 07 September | 13:00 - 14:00

Lunchtime Symposium

Location: Room 111

Recent Advances in the Management of Retinal Disease

Moderator(s):
A. Loewenstein Israel U. Chakravarthy UK

F. Behar-Cohen Switzerland

Inflammation beyond the surface

Y.H. Yoon Korea

OCT biomarkers, can we identify responders vs non-responders

U. Chakravarthy UK

The UK EMR study of DME: a test model for outcomes in real life

A. Loewenstein Israel

Management of DME – clinical studies vs real life outcomes

D. Zur Israel

“The International Retina Group Project” a multicentre study

P. Udaondo Spain

Ozurdex® (dexamethasone) in clinical practice

Location: Room 113

Swept Source OCT & Angiography: Clinical Advances and Applications

Moderator(s):
L. Arias Spain

L. Arias Spain

Clinical decisions for the management of wet AMD patients based on multimodal imaging without dye injection

A. Adan Spain

Utility of Swept Source OCT angio and OCT en-face for the management of posterior uveitis

G. Anastassiou Germany

Choroidal tumors with Swept Source OCT

J. Ruiz-Moreno Spain

Atrophy AMD quantification: accuracy of the automatic measurement of the area and perimeter

Location: Room 114

Retinal Imaging – Pushing the Limits

Moderator(s):

G. Lang Germany

AngioPlex OCT-A

G. Staurenghi Italy

Widefield and ultrawidefield imaging

J-F Korobelnik France

Multi – modal retinal imaging

Friday 08 September | 10:00 - 11:00

Morning Symposium

Location: Room 111

Aflibercept: Innovative Data and Emerging Evidence

Moderator(s): M.S. Figueroa Spain

Friday 08 September | 13:00 - 14:00

Lunchtime Symposium

Location: Room 116

Continuous Microdosing with ILUVIEN®: Real-world Optimisation of the Treatment of Chronic DME

Moderator(s):
H. Hoerauf Germany B. Corcóstegui Spain

  • H. Hoerauf Germany
  • The evolution of clinical management of DME. What can ILUVIEN offer?

  • A. Loewenstein Israel
  • Consider the alternative? It is not all about anti-VEGF

  • F. Goñi Spain
  • Steroids and safety. How big is the elephant in the room?

  • B. Pessoa Portugal
  • Clinical experience and insights with ILUVIEN

  • B. Corcóstegui Spain
  • Implications for clinical practice. Summary and Q&A

Location: Room 113

High-End Imaging Today

Moderator(s):
C. Mody UK

E. Souied France

Multimodal imaging of fibrosis

T. Peto UK

Why MultiColor SLO imaging is a must-have

G. Staurenghi Italy

How to read OCTA images

R. Gallego-Pinazo Spain

OCTA live cases

Location: Room 114

Utilising Ultra-Widefield Retinal Imaging - Clinical Applications and Practice Efficiency

Moderator(s):
P. Stanga UK

A. Joussen Germany

Peripheral retinal ischaemia

S. Sivaprasad UK

Measure of non-perfusion on ultra-widefield imaging

S. Sadda USA

Re-engineering the classification & staging of diabetic retinopathy: implications from ultra-widefield imaging

E. Souied France

Using true ultra-widefield imaging for evaluating sickle cell retinopathy

P. Stanga UK

Ultra-widefield imaging in the diagnosis and management of paediatric retinal diseases

Location: Room 115

New Views on the Retina with Multimodal Imaging: Correlating Structure, Function and Retinal Sensitivity

Moderator(s):
S. Rizzo Italy

R. Abreu-Gonzalez Spain

RS-3000 OCT and wide field OCT-A image

D. Bacherini Italy

Integrated evaluation of vitreoretinal interface disorders: OCT angiography + microperimetry

M. Nagpal India

Going deeper and wider with OCT angiography

Location: Room 118

Nutrition & AMD: From Diagnosis to Treatment

Moderator(s):
A. García Layana Spain A.M. Minnella Italy

C. Delcourt France

S.T.A.R.S questionnaire: for an easy and fast identification of patient at risk of AMD

A.M. Minnella Italy

G. Garhofer Austria

Early supplementation for AMD prevention & treatment - Pros/Cons

A. García Layana Spain

Latest scientific data on vitamin D & AMD. New pre-clinical data

J. Seddon USA

Latest scientific data on vitamin D & AMD. Recent clinical data

H. Bond UK

How to advise patients on nutrition for AMD prevention

Location: Room 111

Real World Evidence: Considerations for the Ophthalmologist

Moderator(s):
T.Y. Wong Singapore

Location: Room 117

Managing Retinal Diseases with Ranibizumab: New Evidence

Moderator(s): J. Monés Spain

J. Monés Spain

Welcome and introduction

U. Chakravarthy UK

Ranibizumab for retinal diseases: the journey so far

F. Holz Germany

Informing retreatment strategies through relevant endpoints

A. Koh Singapore

Optimizing ranibizumab treatment: clinical data and case discussion

Q&A

Saturday 09 September | 10:00 - 11:00

Morning Symposium

Location: Room 111

Advanced Technologies Designed to See More and Do More

Moderator(s):
M.S. Figueroa Spain

R. Tadayoni France

Improve peripheral acuity: broaden the retina view

K. Al Sabti Kuwait

Enhanced depth of field: every time in focus

S. Rizzo Italy

Ultimate high magnification: concentrate on the details

M.S. Figueroa Spain

Explore the color channels: visualize the different structure of the eye

Panel Discussion

Location: Forum Auditorium

Advances in DME Treatment

Moderator(s):
A. Loewenstein Israel

Location: Room 117

New Perspectives in DME Management

Moderator(s):
B. Kuppermann USA M. de Smet Switzerland

J. Zarranz-Ventura Spain

OCTA in DME – now and beyond now

R. Raman India

Cytokines in DR and DME

M. de Smet Switzerland

Predicting retina disease

B. Kuppermann USA

M. Gillies Australia

Debate: early intervention with corticosteroids in DME? Yes/No

L. Kodjikian France

Ozurdex® (dexamethasone) in real life

Location: Room 118

IRIDEX MicroPulse® Laser in Vascular Macular Disease

Moderator(s): S. Vujosevic Italy

M. Zarbin USA

The science, benefits & utility of MicroPulse

S. Vujosevic Italy

MicroPulse laser therapy in DME: morphologic and functional safety and efficacy

M. Escaf Colombia

TxCell™ - guided MicroPulse: safe, effective & immediate care for CSR patients

Saturday 09 September | 13:00 - 14:00

Lunchtime Symposium

Location: Room 117

Impact of Geographic Atrophy: Enhancing Our Understanding of the Disease

Moderator(s):
J. Monés Spain

J. Monés Spain

Welcome and introduction

R. Tadayoni France

Diagnostic paradigms of geographic atrophy

N. Bressler USA

Measuring disease-specific functional outcomes

F. Holz Germany

Geographic atrophy: a progressive disease

U. Chakravarthy UK

Characterizing disease burden using real-world data

Q&A

Location: Room 120

A New Chapter in Retina Surgery with Bausch + Lomb

Moderator(s):
S. Rizzo Italy

M. Amon Austria

The Stellaris® PC - latest illumination and laser technology

I. Jürgens Spain

Experience with the Stellaris® PC in combined surgery

C. Awh USA

The next chapter for the Stellaris® platform - introducing the hypersonic vitrectomy technology

P. Stanga UK

First clinical experience in human eyes with the hypersonic vitrectomy device

Location: Room 111

Ranibizumab for nAMD: New Evidence to Improve Patient Care

Moderator(s):
M.S. Figueroa Spain

M.S. Figueroa Spain

Welcome and introduction

A. Loewenstein Israel

Navigating the evidence base of ranibizumab for nAMD

P. Mitchell Australia

Leveraging real-world data to address current challenges in practice

R. Tadayoni France

Treat and extend: efficacy without burden

Case discussion followed by Q&A

Location: Room 118

Can Innovation in Small Gauge Surgery Enhance Patient Outcomes Without Compromising Surgeon Control?

Moderator(s):
P. Stalmans Belgium

M. Romano Italy

Why fluidics should influence your choice of vitrectome?

M. Vecchi Italy

Can you rely on your VR machine in complicated cases?

M. Ruiz Spain

Why is PFCL safety paramount?

M. Pavlidis Germany

27G limitations & solutions